Özet:

Aim: In this study, we aimed to determine the blood transfusion characteristics, related factors and results in patients followed in the COVID-19 Intensive Care Unit(ICU).Material and Methods: The files of patients who were followed up in the COVID-19 ICU between March 21, 2020 and June 01, 2020 with the diagnosis of COVID-19 and stayed in the ICU for more than 48 hours were retrospectively reviewed. Demographic data of the patients, laboratory data (hemogram, coagulation parameters, inflammatory markers, arterial blood gas parameters), heart rate, arterial blood pressure, bleeding findings, development of disseminated intravascular coagulation (DIC), vasopressor requirement and blood transfusion need were recorded. Results: The length of stay in the intensive care unit [27 (4-65) days] of the patients who received blood transfusion was significantly higher than those who did not [5 (0-30) days] (p<0.001). No significant difference was found between the groups in terms of age, Acute Physiology and Chronic Health Evaluation II(APACHE II) and Glasgow Coma Score (GCS) score averages, and gender, Diabetes mellitus (DM), hypertension, Coronary artery disease (CAD), chronic kidney disease (CKD) and asthma rates (p> 0.05). Chronic obstructive pulmonary disease (COPD) rates were significantly higher in those who received blood transfusion (33.3% vs 0.0%) (p=0.026). The fatality rate was 44.4% in the blood transfused group, and 21.1% in the non-transfused group (p=0.371). Conclusion: As a result of our study, it was determined that patients with a diagnosis of COPD in the COVID-19 ICU, who had a severe clinic and intubation need, mechanical ventilation, and who were hospitalized in the intensive care unit for a long time developed more anemia and blood transfusion, and mortality was higher in patients who underwent transfusion.

Anahtar Kelimeler: